RHN001-Dx (99mTc-PSMA)

N/A

Report date: 2025/11/25 15:56:56

NME

Base Information

Drug NameRHN001-Dx (99mTc-PSMA)

Drug Alias Name99mTc-RHN001technetium-99m (99mTc)Technetium 99m-RHN 001

ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Technetium > 99mTc +[5]

Mechanisms of ActionProstate-Specific Membrane Antigen modulatorsRadionuclide imaging enhancersSingle-photon emission-computed tomography enhancers

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesTelix Pharmaceuticals Ltd Heidelberg University Hospital

China Registration ClassN/A

Develop Information

Active CompaniesRhine Pharmaceuticals LLC

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A